Prospective study of endogenous tissue plasminogen activator and risk of stroke (Q41036094)

25 September 2017

Prospective study of endogenous tissue plasminogen activator and risk of stroke (English)

1 reference

25 September 2017

1 reference

2

C H Hennekens

1 reference

25 September 2017

3

M J Stampfer

1 reference

25 September 2017

4

J E Manson

1 reference

25 September 2017

1

P M Ridker

1 reference

25 September 2017

D E Vaughan

5

1 reference

PubMed ID

7909008

25 September 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

25 September 2017

1 reference

25 September 2017

343

1 reference

25 September 2017

8903

1 reference

25 September 2017

940-943

1 reference

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Primary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Hematologic disorders and ischemic stroke. A selective review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Hemostatic markers in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Lipoprotein(a) as a strong indicator for cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990064-7

7 January 2021

10.1016/S0140-6736(94)90064-7

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

7909008